Basic info
Industry
pharmaceutical manufacturing
Sectors
orphan disease
Biotechnology
rare disease
inborn errors of energy metabolism
mitochondria
melas
Pharmaceutical
leigh syndrome
Life cell quantitative imaging
mitochondrial disease
midd
compound development and testing
mitochondrial medicine
Date founded
2012
Funding rounds raised
Total raised
$3.8M
from 1 investors over 1 rounds
K
Khondrion raised $3.8M on October 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)